Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 1/20 | 0.49 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 15/20 | 0.46 |
| ▸ | CA1 | P00915 | 14/20 | 0.46 |
| ▸ | CA9 | Q16790 | 11/20 | 0.46 |
| ▸ | CA12 | O43570 | 9/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 3/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31682090 | 1.00 | ITGB1 (0.49) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682046 | 1.00 | ITGB1 (0.49) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682059 | 0.94 | CA1 (0.47) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682056 | 0.94 | CA1 (0.47) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682092 | 0.91 | ITGB1 (0.47) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682116 | 0.91 | ITGB1 (0.47) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682079 | 0.91 | ITGB1 (0.47) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682083 | 0.89 | CA1 (0.49) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31682108 | 0.89 | CA1 (0.49) | ITGB1ITGA4CA2CA1CA9 | |
| SCHEMBL31681999 | 0.86 | CA1 (0.44) | ITGB1ITGA4CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893934-B1 | INSULIN CONJUGATES | SANOFI SA (FR) | 2025-09-10 | — | — | EP | disclosed |
| US-20250206798-A1 | INSULIN CONJUGATES | SANOFI SA (FR) | 2025-06-26 | — | — | US | disclosed |
| US-12195510-B2 | Insulin conjugates | SANOFI (FR) | 2025-01-14 | — | — | US | disclosed |
| US-20220048968-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2022-02-17 | — | — | US | disclosed |
| US-20220048968-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2022-02-17 | — | — | US | disclosed |
| EP-3893934-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2021-10-20 | — | — | EP | disclosed |
| EP-3894391-A1 | PEPTIDE BINDER | SANOFI (FR) | 2021-10-20 | — | — | EP | disclosed |
| CN-113423691-A | Peptide binding agents | 赛诺菲 | 2021-09-21 | — | — | CN | disclosed |
| CN-113395982-A | Insulin conjugates | 赛诺菲 | 2021-09-14 | — | — | CN | disclosed |
| WO-2020120463-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120479-A1 | PEPTIDE BINDER | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120463-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120479-A1 | PEPTIDE BINDER | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| US-20200181223-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-11 | — | — | US | disclosed |
| US-20200181223-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181223-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | ITGB1 2907/4885ITGA4 3171/4885CA2 1521/4885 |
| US-20220048968-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | ITGB1 2907/4885ITGA4 3171/4885CA2 1521/4885 |
| US-12195510-B2 | Insulin conjugates | IAPP, INSR, IGF1R | ITGB1 2907/4885ITGA4 3171/4885CA2 1521/4885 |
| US-20250206798-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | ITGB1 2907/4885ITGA4 3171/4885CA2 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.